Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Final IRS Device Tax Rule Changes Little From Draft As Industry Focuses On Repeal Effort

This article was originally published in The Gray Sheet

Executive Summary

Though the IRS final regulation offers some wins for industry, manufacturers continue to seek repeal of the device tax.

You may also be interested in...



Hospitals, GPOs Cry Foul On Industry Attempts To Pass On Excise Tax

Some device firms are trying to pass the 2.3 percent medical device excise tax onto hospitals in the form of price increases; hospitals and group purchasing organizations argue this subverts the intent of the tax provision.

Hospitals, GPOs Cry Foul On Industry Attempts To Pass On Excise Tax

Some device firms are trying to pass the 2.3 percent medical device excise tax onto hospitals in the form of price increases; hospitals and group purchasing organizations argue this subverts the intent of the tax provision.

News In Brief

News on DePuy hip liability suits, U.S. v. Caronia and more.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031795

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel